Literature DB >> 10790231

P53 mutations analysis in benign and malignant breast lesions: using needle rinses from fine-needle aspirations.

S Gudlaugsdottir1, V Sigurdardottir, M Snorradottir, J G Jonasson, H Ogmundsdottir, J E Eyfjord.   

Abstract

The fine-needle aspiration (FNA) technique is a widely used method for diagnostic assessment of breast diseases. In the current study we investigated the feasibility of sampling material for genetic studies from the same FNA samples as would be used for breast cytology. After making smears for cytological examination, the needle was rinsed into phosphate-buffered saline (PBS) solution. The material gained was sufficient for a polymerase chain reaction (PCR)-based study. As the FNA samples reflect a broad range of breast diseases, it is possible to study genetic changes at various stages of the neoplastic process. We looked for mutations in the p53 tumor suppressor gene in 198 FNA needle rinses, 42 from carcinomas and 156 from cytologically benign lesions. In the malignant samples, 22% carried mutations in the p53 gene. We also looked for p53 mutations in matching tissue sections from tumors and found the FNA needle rinses to represent the tumor well. In addition, three mutations in cytologically benign lesions were found, but none of these 3 patients were diagnosed with malignant tumors in the time frame of the study. The clinical significance of p53 mutations in benign breast tissue remains to be determined. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10790231     DOI: 10.1002/(sici)1097-0339(200005)22:5<268::aid-dc2>3.0.co;2-x

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

1.  Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.

Authors:  Valgerdur Birgisdottir; Olafur A Stefansson; Sigridur K Bodvarsdottir; Holmfridur Hilmarsdottir; Jon G Jonasson; Jorunn E Eyfjord
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

2.  Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring.

Authors:  H M Ball; T R Hupp; D Ziyaie; C A Purdie; N M Kernohan; A M Thompson
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.